Ribera Healthcare Clinic

Ribera Healthcare Clinic operates as a multi-specialty family medicine practice in Albuquerque, New Mexico, serving patients across the lifespan from pediatrics through geriatrics while incorporating regenerative medicine protocols into primary care. The clinic bridges conventional family medicine with metabolic optimization therapies, offering both in-office appointments and telehealth consultations for New Mexico residents seeking continuity of care that extends beyond standard primary care visits. This hybrid model allows established patients to access follow-up consultations and medication management remotely while maintaining the option for comprehensive in-person evaluations when clinically indicated.

The regenerative medicine component at Ribera Healthcare Clinic centers on peptide-based metabolic therapies, specifically semaglutide and tirzepatide for weight management and metabolic dysfunction, alongside NAD+ protocols for cellular energy optimization and age-related decline. Semaglutide, a GLP-1 receptor agonist, is prescribed as part of structured weight loss programs that include metabolic assessment, dietary guidance, and ongoing monitoring of glycemic control and cardiovascular risk factors. Tirzepatide, which activates both GLP-1 and GIP receptors, is utilized for patients requiring dual incretin therapy to address obesity and insulin resistance. NAD+ supplementation protocols are integrated for patients experiencing fatigue, cognitive decline, or seeking cellular repair support as part of longevity-focused care plans. These peptide therapies are administered within the context of comprehensive primary care, allowing providers to monitor interactions with existing medications and adjust treatment based on complete patient health profiles.

The clinical team includes nurse practitioners and primary care providers who manage both acute episodic care and chronic disease management alongside peptide therapy protocols. Providers maintain patient histories that inform personalized treatment decisions, particularly important when introducing metabolic therapies to patients with complex medication regimens or multiple comorbidities. The practice emphasizes documentation and communication systems that allow patients to message providers between visits, request prescription refills, and receive guidance on treatment adjustments. This infrastructure supports the monitoring requirements inherent in peptide therapy, where dose titration and side effect management often require frequent provider-patient communication during initial treatment phases.

Patients at Ribera Healthcare Clinic can expect a primary care environment where regenerative therapies are offered as extensions of comprehensive health management rather than isolated interventions. Initial consultations for peptide therapy include review of medical history, current medications, metabolic labs including fasting glucose and lipid panels, and assessment of contraindications specific to GLP-1 agonists or NAD+ protocols. The office manager coordinates scheduling for both in-person and telehealth visits, with New Mexico telehealth regulations allowing remote prescribing for established patients. Follow-up protocols typically include monthly check-ins during the first three months of semaglutide or tirzepatide therapy to monitor weight trends, gastrointestinal tolerance, and metabolic markers, with adjustments made based on individual response patterns.

Ribera Healthcare Clinic's position as a family medicine practice offering regenerative therapies provides continuity that standalone peptide clinics cannot replicate—providers have access to complete patient records, vaccination histories, and longitudinal health data that inform safer peptide prescribing. The Albuquerque location serves patients throughout the metro area who prefer a single provider relationship that encompasses both primary care needs and elective metabolic optimization. The hybrid consultation model accommodates working patients and those in rural New Mexico areas who benefit from telehealth access while maintaining the option for in-office labs, physical exams, and procedures that cannot be conducted remotely. This integrated approach positions peptide therapy within a broader health optimization framework rather than as a standalone cosmetic or performance intervention.